Biotechnology and medical technology organizations now operate in an environment where artificial intelligence accelerates target discovery, reshapes clinical trial design, and informs pricing and portfolio decisions. At the same time, companies face global competition and heightened scrutiny of data governance and AI deployment. The Katz School's master's in biotech prepares you to integrate emerging technologies with regulatory and commercial strategy, make decisions under uncertainty, and lead across the full product lifecycle in a field defined by scientific rigor and technological acceleration. This interdisciplinary program prepares you to work across the full biotech value chain, from drug discovery and clinical trials through regulatory approval and commercialization. You'll develop the scientific fluency and strategic judgment to evaluate translational risk, structure commercialization pathways, and align intellectual property and reimbursement strategy with data-driven R&D. Through applied projects and a capstone experience, you'll build investor-ready strategies that translate innovation into regulated, scalable products.
Bachelors degree - with typical majors in biology, pre-med or any STEM discipline, as well as business, finance, marketing, public health, and other clinical majors. Prerequisites - some biology or life science coursework or professional experience in business, finance, law or marketing. If no biology background, a life science course is available in the first semester.
Seçtiğiniz bölüme bağlı olarak farklı IELTS koşulları olabilir.